InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,186.43
(
0.11%
)
US TECH 100
17,606.80
(
-0.02%
)
Dow Jones
38,872.37
(
0.05%
)
Brent Oil
83.10
(
-0.46%
)
Bitcoin
63,183.56
(
0.03%
)
Post# of 64380
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

fly_fisherman

Send PM Follow Ignore
Followers 609
Posts 26741
Boards Moderated 1
Alias Born 08/12/2010

fly_fisherman

Re: Millenium323 post# 21012

Friday, 08/18/2017 10:14:25 AM

Friday, August 18, 2017 10:14:25 AM

Post# of 64380
I believe adding up.....


The debt in the 10Q did it not reflect 1.5 million dollars?

Folks that is peanuts compared to a 30 - 100 million dollar market cap company for starters.

For a typical stinky pinky 1.5 million is massive debt. Not here especially with a bio tech representing a huge pipeline, patents, and Orphan Drug Status.

It is unfortunate what the toxic holders are doing to this company. Honestly and I do not normally say this but they stink. I am a true capitalist but even I have my limits. They have already made their money and then some. I would love to see a legitimate financier that truly cares about getting the pediatric MS drug to market to take these toxic holder to the limit....

Just my humble opinion!

ALL POSTS are just my opinion! Never BUY/SELL stock based on only them! Perform your own DD and make your own decision!

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
InvestorsHub NewsWire

FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM

Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM

NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM

ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM

Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM

Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM

Start posting your company's news
Only $200 per official company press release!